Desai K, Wanggou S, Luis E, Whetstone H, Yu C, Vanner R
Nat Commun. 2025; 16(1):1092.
PMID: 39904987
PMC: 11794873.
DOI: 10.1038/s41467-024-54858-y.
Dave B, Tailor J
BMC Cancer. 2024; 24(1):1465.
PMID: 39609728
PMC: 11603633.
DOI: 10.1186/s12885-024-13187-5.
van Bree N, Oppelt A, Lindstrom S, Zhou L, Boutin L, Coyle B
Neuro Oncol. 2024; 27(3):779-794.
PMID: 39383211
PMC: 11889719.
DOI: 10.1093/neuonc/noae210.
Tao R, Han K, Wu S, Friske J, Roussel M, Northcott P
Genes Dev. 2024; 39(1-2):4-17.
PMID: 39231614
PMC: 11789489.
DOI: 10.1101/gad.351936.124.
Clairmont C, Gell J, Lau C
Cancer Control. 2024; 31:10732748241270564.
PMID: 39118322
PMC: 11311176.
DOI: 10.1177/10732748241270564.
G-quadruplexes are a source of vulnerability in deficient granule cell progenitors and medulloblastoma.
Keahi D, Sanders M, Paul M, Webster A, Fang Y, Wiley T
bioRxiv. 2024; .
PMID: 39091814
PMC: 11291086.
DOI: 10.1101/2024.07.20.604431.
A simple and scalable zebrafish model of Sonic hedgehog medulloblastoma.
Casey M, Chan P, Li Q, Zu J, Jette C, Kohler M
Cell Rep. 2024; 43(8):114559.
PMID: 39078737
PMC: 11404834.
DOI: 10.1016/j.celrep.2024.114559.
Integrating Ataxia Evaluation into Tumor-Induced Hearing Loss Model to Comprehensively Study NF2-Related Schwannomatosis.
Lu S, Yin Z, Chen J, Wu L, Sun Y, Gao X
Cancers (Basel). 2024; 16(11).
PMID: 38893082
PMC: 11171041.
DOI: 10.3390/cancers16111961.
LOXL1-AS1 contributes to metastasis in sonic-hedgehog medulloblastoma by promoting cancer stem-like phenotypes.
Do A, Wu K, Chu S, Giang L, Lin Y, Chang C
J Exp Clin Cancer Res. 2024; 43(1):130.
PMID: 38689348
PMC: 11059759.
DOI: 10.1186/s13046-024-03057-0.
Zebrafish-A Suitable Model for Rapid Translation of Effective Therapies for Pediatric Cancers.
Roy D, Subramaniam B, Chong W, Bornhorst M, Packer R, Nazarian J
Cancers (Basel). 2024; 16(7).
PMID: 38611039
PMC: 11010887.
DOI: 10.3390/cancers16071361.
Single-cell transcriptomic sequencing identifies subcutaneous patient-derived xenograft recapitulated medulloblastoma.
Gao J, Zhao Y, Wang Z, Liu F, Chen X, Mo J
Animal Model Exp Med. 2024; 8(3):458-472.
PMID: 38477441
PMC: 11904117.
DOI: 10.1002/ame2.12399.
An Update on Emergent Nano-Therapeutic Strategies against Pediatric Brain Tumors.
Ravi Kiran A, Kumari G, Krishnamurthy P, Johnson A, Kenchegowda M, Osmani R
Brain Sci. 2024; 14(2).
PMID: 38391759
PMC: 10886772.
DOI: 10.3390/brainsci14020185.
Cellular development and evolution of the mammalian cerebellum.
Sepp M, Leiss K, Murat F, Okonechnikov K, Joshi P, Leushkin E
Nature. 2023; 625(7996):788-796.
PMID: 38029793
PMC: 10808058.
DOI: 10.1038/s41586-023-06884-x.
Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy.
Chehelgerdi M, Dehkordi F, Chehelgerdi M, Kabiri H, Salehian-Dehkordi H, Abdolvand M
Mol Cancer. 2023; 22(1):189.
PMID: 38017433
PMC: 10683363.
DOI: 10.1186/s12943-023-01873-0.
Vector enabled CRISPR gene editing - A revolutionary strategy for targeting the diversity of brain pathologies.
Forgham H, Liu L, Zhu J, Javed I, Cai W, Qiao R
Coord Chem Rev. 2023; 487.
PMID: 37305445
PMC: 10249757.
DOI: 10.1016/j.ccr.2023.215172.
The emerging roles of Hedgehog signaling in tumor immune microenvironment.
Wang J, Cui B, Li X, Zhao X, Huang T, Ding X
Front Oncol. 2023; 13:1171418.
PMID: 37213270
PMC: 10196179.
DOI: 10.3389/fonc.2023.1171418.
Addressing blood-brain-tumor-barrier heterogeneity in pediatric brain tumors with innovative preclinical models.
Morris E, Daignault-Mill S, Stehbens S, Genovesi L, Lagendijk A
Front Oncol. 2023; 13:1101522.
PMID: 36776301
PMC: 9909546.
DOI: 10.3389/fonc.2023.1101522.
Chromosomal Instability Characterizes Pediatric Medulloblastoma but Is Not Tolerated in the Developing Cerebellum.
Bockaj I, Martini T, Smit M, Armandari I, Bakker B, Wardenaar R
Int J Mol Sci. 2022; 23(17).
PMID: 36077248
PMC: 9456393.
DOI: 10.3390/ijms23179852.
Single-cell DNA sequencing identifies risk-associated clonal complexity and evolutionary trajectories in childhood medulloblastoma development.
Danilenko M, Zaka M, Keeling C, Crosier S, Lyman S, Finetti M
Acta Neuropathol. 2022; 144(3):565-578.
PMID: 35831448
PMC: 9381458.
DOI: 10.1007/s00401-022-02464-x.
tumors, but not tumor-derived cell lines, are adrenergic lineage, GD2+, and responsive to anti-GD2 antibody therapy.
McNerney K, Karageorgos S, Ferry G, Wolpaw A, Burudpakdee C, Khurana P
Oncoimmunology. 2022; 11(1):2075204.
PMID: 35646475
PMC: 9132414.
DOI: 10.1080/2162402X.2022.2075204.